Immune Booster 32: Natural infection versus vaccine protection with Jenna Guthmiller

Immunology researcher Jenna Guthmiller examines the complexities of B-cell and antibody responses to influenza, focusing on the structural challenges of targeting the virus's conserved stock domain. Unlike the highly variable head domain, the stock domain contains critical fusion machinery, yet it remains difficult for the immune system to access due to steric hindrance. This research highlights how initial viral exposure creates "immune imprinting," which dictates future susceptibility to variants, as seen in age-specific responses to H1N1. Current vaccine development strategies, including chimeric hemagglutinin constructs, attempt to overcome this bias by focusing the immune system on these conserved regions. By understanding how B-cells undergo somatic hypermutation and affinity maturation, scientists aim to design more effective, durable vaccines that provide broader protection against rapidly evolving pathogens.